We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+8.27%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$21.8B
AUM Growth
+$3.36B
Cap. Flow
+$2.78B
Cap. Flow %
12.74%
Top 10 Hldgs %
12.04%
Holding
3,109
New
1,280
Increased
559
Reduced
519
Closed
699

Sector Composition

Rank Sector Weight
1 Healthcare 20.03%
2 Consumer Discretionary 13.15%
3 Technology 10.68%
4 Financials 9.81%
5 Communication Services 8.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CHRS icon
1926
Coherus Oncology
CHRS
$222M
$505K ﹤0.01%
+34,610
New +$588K
SYM icon
1927
Symbotic
SYM
$5.39B
$505K ﹤0.01%
+50,000
New +$511K
ADERW
1928
CALL
DELISTED
26 Capital Acquisition Corp Warrant
ADERW
$505K ﹤0.01%
+52,084
New +$48K
AEM icon
1929
Agnico Eagle Mines
AEM
$71.9B
$503K ﹤0.01%
8,700
+2,931
+51% +$190K
MTSI icon
1930
MACOM Technology Solutions
MTSI
$19B
$503K ﹤0.01%
8,678
+975
+13% +$60.4K
NWN icon
1931
Northwest Natural Holdings
NWN
$2.18B
$501K ﹤0.01%
9,294
-4,422
-32% -$212K
CTRA
1932
DELISTED
Coterra Energy
CTRA
$500K ﹤0.01%
+26,609
New +$490K
TANH icon
1933
Tantech Holdings
TANH
$6.15M
$500K ﹤0.01%
+36
New +$591K
DGII icon
1934
Digi International
DGII
$2.53B
$499K ﹤0.01%
+26,287
New +$545K
VTVT icon
1935
vTv Therapeutics
VTVT
$122M
$499K ﹤0.01%
+4,425
New +$435K
WTTR icon
1936
Select Water Solutions
WTTR
$2.24B
$497K ﹤0.01%
+99,893
New +$581K
HMCOW
1937
CALL
DELISTED
HumanCo Acquisition Corp. Warrant
HMCOW
$497K ﹤0.01%
+49,995
New +$103K
NXTC icon
1938
NextCure
NXTC
$22.1M
$496K ﹤0.01%
4,130
-431
-9% -$62.4K
SRT
1939
DELISTED
Startek Inc.
SRT
$495K ﹤0.01%
+62,322
New +$516K
HUMA icon
1940
Humacyte
HUMA
$170M
$494K ﹤0.01%
+45,590
New +$498K
CCV.WS
1941
CALL
DELISTED
Churchill Capital Corp V Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share
CCV.WS
$494K ﹤0.01%
+49,995
New +$125K
ENJYW
1942
CALL
DELISTED
Enjoy Technology, Inc. Warrant
ENJYW
$494K ﹤0.01%
+49,995
New +$84.9K
TCRR
1943
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$491K ﹤0.01%
22,211
+1,707
+8% +$46.5K
EFTR
1944
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
$486K ﹤0.01%
+1,999
New +$491K
BIOTW
1945
CALL
DELISTED
Biotech Acquisition Company Warrant
BIOTW
$485K ﹤0.01%
+49,993
New +$35.2K
ZEPP
1946
Zepp Health
ZEPP
$68M
$484K ﹤0.01%
+11,227
New +$652K
VTIQ
1947
DELISTED
VectoIQ Acquisition Corp. II Class A Common Stock
VTIQ
$484K ﹤0.01%
+48,770
New +$491K
EPWR.WS
1948
CALL
DELISTED
Empowerment & Inclusion Capital I Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share
EPWR.WS
$483K ﹤0.01%
+49,996
New +$31.7K
HCCCW
1949
CALL
DELISTED
Healthcare Capital Corp. Warrant
HCCCW
$483K ﹤0.01%
+49,995
New +$34.1K
MOD icon
1950
Modine Manufacturing
MOD
$11B
$482K ﹤0.01%
32,635
-131,670
-80% -$1.87M

Similar funds

Marshall Wace's Q1 2021 Portfolio in Review

As of Q1 2021, Marshall Wace held 3,109 positions worth $21.8B, up 18% from $18.5B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Marshall Wace deployed $2.78B of net new capital in Q1 2021, opening 1,280 new positions and adding to 559 existing holdings. Its largest new stake was Paramount Global Class B: 5,936,494 shares worth $268M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Thermo Fisher Scientific, an estimated $204M trimmed.

  • Marshall Wace's largest Q1 2021 buy was Paramount Global Class B: 5,936,494 shares worth $268M.
  • Marshall Wace added most to Farfetch Limited Class A Ordinary Shares in Q1 2021, an estimated $182M increase.
  • Marshall Wace's biggest Q1 2021 reduction was Thermo Fisher Scientific, cutting an estimated $204M.
  • Marshall Wace fully exited Vanguard Intermediate-Term Corporate Bond ETF in Q1 2021, selling an estimated $76.2M.
  • Marshall Wace's ten largest holdings make up 12% of its $21.8B portfolio in Q1 2021.
  • Marshall Wace opened 1,280 new positions and closed 699 in Q1 2021.
  • Marshall Wace's portfolio value rose 18% quarter-over-quarter to $21.8B.

Based on Marshall Wace's 13F filing for Q1 2021, filed 17 May 2021.